Innova Captab (INNOVACAP) | Stock Overview & Key Data
Innova Captab Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹1,260.00 on January 6, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Innova Captab
INNOVACAP
|
41.43B Small-cap | 8.95% | 10.45% | 34.08% | 34.58% | 28.37% | 3.87% | 74.08% | 74.08% | 74.08% | 74.08% | 74.08% |
|
Sun Pharmaceutical
SUNPHARMA
|
3.88T Large-cap | 0.96% | -3.84% | 1.28% | 0.50% | 4.93% | 7.10% | 82.23% | 170.41% | 143.23% | 656.74% | 2,541.29% |
|
Divi's Laboratories
DIVISLAB
|
1.69T Large-cap | 1.34% | -2.25% | 8.85% | 4.11% | 4.17% | -0.43% | 85.44% | 58.15% | 496.33% | 1,610.60% | 10,946.76% |
|
Sun Pharma Advanced
SPARC
|
46.75B Small-cap | 12.49% | 39.95% | 100.62% | 67.89% | 69.61% | 34.88% | 14.54% | -3.55% | -20.47% | 148.26% | -23.02% |
|
Gujarat Themis
GUJTHEM
|
35.41B Small-cap | -4.89% | 4.00% | 38.98% | -1.40% | -12.59% | 15.75% | 76.92% | 76.92% | 76.92% | 76.92% | 76.92% |
|
Aarti Drugs
AARTIDRUGS
|
33.96B Small-cap | 2.55% | 2.08% | 10.70% | -4.44% | -9.90% | -19.85% | -20.05% | -48.38% | 225.65% | 2,200.12% | 3,739.88% |
Ownership & Short Interest
Calculate Your Innova Captab Investment Returns
Long-Term Investment Performance Analysis
Innova Captab stock price in Dec 2023 was ₹541.40, A ₹1,000.00 lump sum investment in Innova Captab made 2 years ago would be worth approximately ₹1,750.92 today, representing a solid return of 75.09%. This translates to an annualized return (CAGR) of 25.43%.
2 Years 5 Months Investment Scenario (Dec 2023 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is INNOVACAP's 52-week high and low?
- In the last 52 weeks, Innova Captab reached a high of ₹978.00 (on June 15, 2026) and a low of ₹622.00 (on March 2, 2026).
- What is the market cap and P/E ratio for INNOVACAP?
- Curious about Innova Captab's size and valuation? Its market capitalization stands at 41.43B. When it comes to valuation, the P/E ratio (trailing twelve months) is 31.20, and the forward P/E (looking ahead) is 21.90.
- Does INNOVACAP pay dividends? If so, what's the yield?
- Yes, Innova Captab is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.30%, and the company has paid an average of ₹0.67 per share annually over the past 3 years.
- Who are Innova Captab's main competitors or similar companies to consider before investing?
When looking at Innova Captab, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.88T Healthcare Drug Manufacturers - Specialty & Generic 7.10% 82.23% Divi's Laboratories
DIVISLAB1.69T Healthcare Drug Manufacturers - Specialty & Generic -0.43% 85.44% Sun Pharma Advanced
SPARC46.75B Healthcare Drug Manufacturers - Specialty & Generic 34.88% 14.54% Gujarat Themis
GUJTHEM35.41B Healthcare Drug Manufacturers - Specialty & Generic 15.75% 76.92% Aarti Drugs
AARTIDRUGS33.96B Healthcare Drug Manufacturers - Specialty & Generic -19.85% -20.05% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Innova Captab Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Innova Captab's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 13.37%, the Debt to Equity ratio from the most recent quarter is 32.95, and its Gross Profit Margin stands at 35.19%.
- What is the recent revenue and earnings growth for INNOVACAP?
- Looking at Innova Captab's growth, its revenue over the trailing twelve months (TTM) was INR15B. Compared to the same quarter last year (YoY), quarterly revenue grew by 42.30%, and quarterly earnings saw a YoY growth of 23.20%.
- How much of INNOVACAP stock is held by insiders and institutions?
- Wondering who owns Innova Captab stock? Company insiders (like executives and directors) hold about 72.19% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 19.22%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.